eYugoslavia.comAbbott, Biogen Idec announce additional results from daclizumab HYP Phase 2b …News-Medical.netToday Biogen Idec (NASDAQ: BIIB) and Abbott (NYSE: ABT) announced additional results from the SELECT Phase 2b trial, the first of two registr…
Baiduri Bank holds blood donation drive – Borneo Bulletin
Borneo BulletinBaiduri Bank holds blood donation driveBorneo BulletinIn collaboration with the RIPAS Hospital Blood Bank, Baiduri Bank Group recently held a blood donation campaign at its Training Centre in Kiarong Complex. The blood donation campaign …
Abbott Laboratories : Biogen Idec et Abbott présentent les résultats positifs … – Zonebourse.com
Abbott Laboratories : Biogen Idec et Abbott présentent les résultats positifs …Zonebourse.comLe DAC HYP (Daclizumab high-yield process) est une formulation du daclizumab à administration sous-cutanée qui constitue une thérapie expérimentale pou…
Healthy Living: Organ donation – YNN Hudson Valley
Healthy Living: Organ donationYNN Hudson Valley“We're really encouraging everyone to have a conversation with their family to say that they would like to become an organ donor,” said Kochik. It's a decision Charity knew all about before she…
Student helps raise money for friend who needs stem cell transplant – Standard Speaker
Standard SpeakerStudent helps raise money for friend who needs stem cell transplantStandard SpeakerLang had mentioned getting a stem cell transplant – a procedure that could help him to his feet but is not covered by medical insurance. And then it came…
Biogen Idec, Abbott Say SELECT Phase 2B Trial For RRMS Compound Met Primary Goal – RTT News
eYugoslavia.comBiogen Idec, Abbott Say SELECT Phase 2B Trial For RRMS Compound Met Primary GoalRTT News(RTTNews) – Biotechnology firms Biogen Idec Inc. (BIIB: News ) and Abbott Laboratories (ABT: News ) announced Saturday that the investigational compo…
Biogen Idec and Abbott Present Positive Data for Daclizumab HYP from Select … – EON: Enhanced Online News (press release)
EON: Enhanced Online News (press release)Biogen Idec and Abbott Present Positive Data for Daclizumab HYP from Select …EON: Enhanced Online News (press release)The SELECT data was presented in a late-breaking platform presentation, called A randomized…
Biogen Idec and Abbott Present Positive Data for Daclizumab HYP from Select … – Victoria Times Colonist
eYugoslavia.comBiogen Idec and Abbott Present Positive Data for Daclizumab HYP from Select …Victoria Times ColonistToday Biogen Idec (NASDAQ: BIIB) and Abbott (NYSE: ABT) announced additional results from the SELECT Phase 2b trial, the first of two r…
Biogen Idec e Abbott presentano i risultati positivi relativi all'esperimento … – ANSA.it
Biogen Idec e Abbott presentano i risultati positivi relativi all'esperimento …ANSA.itOggi Biogen Idec (NASDAQ: BIIB) e Abbott (NYSE: ABT) hanno presentato ulteriori risultati dalla fase 2b dello studio SELECT, il primo di due studi per la regist…
Toddler's Death Stirs Ire in China – Wall Street Journal
Wall Street JournalToddler's Death Stirs Ire in ChinaWall Street JournalThe two-year-old, Wang Yue, had been in critical condition and verging on brain death since arriving at a military hospital in the city of Guangzhou a week ago. She succumbed t…